Alexis Desieno Sells 7,487 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO Alexis Desieno sold 7,487 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $3.08, for a total value of $23,059.96. Following the completion of the transaction, the chief financial officer now owns 97,849 shares of the company’s stock, valued at $301,374.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Cardlytics Stock Performance

NASDAQ:CDLX opened at $3.07 on Thursday. The stock has a market cap of $149.76 million, a P/E ratio of -0.69 and a beta of 1.68. The stock has a 50 day simple moving average of $4.56 and a 200 day simple moving average of $8.59. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. Cardlytics, Inc. has a 1-year low of $2.89 and a 1-year high of $20.52.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.12. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The firm had revenue of $69.64 million for the quarter, compared to analyst estimates of $75.39 million. During the same quarter last year, the company earned ($0.57) EPS. The company’s revenue was down 9.2% on a year-over-year basis. Research analysts anticipate that Cardlytics, Inc. will post -1.72 earnings per share for the current year.

Hedge Funds Weigh In On Cardlytics

A number of hedge funds have recently added to or reduced their stakes in CDLX. Clear Street Markets LLC bought a new position in Cardlytics during the 4th quarter worth $199,000. General Equity Holdings LP increased its stake in Cardlytics by 31.0% during the 4th quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock worth $5,748,000 after acquiring an additional 147,843 shares during the period. Virtu Financial LLC bought a new position in Cardlytics during the 4th quarter worth $219,000. Los Angeles Capital Management LLC increased its stake in shares of Cardlytics by 36.1% in the 1st quarter. Los Angeles Capital Management LLC now owns 106,916 shares of the company’s stock valued at $1,549,000 after purchasing an additional 28,370 shares during the last quarter. Finally, Check Capital Management Inc. CA increased its stake in shares of Cardlytics by 83.1% in the 1st quarter. Check Capital Management Inc. CA now owns 42,475 shares of the company’s stock valued at $615,000 after purchasing an additional 19,275 shares during the last quarter. Institutional investors own 68.10% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Craig Hallum cut Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Northland Securities cut Cardlytics from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $7.00 to $5.00 in a research report on Friday, August 16th. Lake Street Capital cut Cardlytics from a “buy” rating to a “hold” rating and cut their price objective for the company from $18.00 to $5.00 in a research report on Thursday, August 8th. Bank of America cut Cardlytics from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $4.00 to $3.50 in a research report on Thursday, August 15th. Finally, Needham & Company LLC cut Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $7.50.

Read Our Latest Stock Analysis on Cardlytics

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.